Seeking Alpha

AstraZeneca could buy Actelion: Citi

  • AstraZeneca (AZN) may be interested in buying Actelion (ALIOF), Citi says, in a note that sent shares of the Swiss biotech surging in overseas trade.
  • Here's the actual quote (via Reuters): "Creative corporate finance
    ... coupled with 'long runway' acquisitions such as Actelion could provide a useful bridge to organically fueled growth."
  • Citi thinks the deal would boost operating profits by double-digits for AZN.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector